Kuppan Gokulakrishnan

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Cardiovascular Disease

Top Venues

Acta diabetologica

Annals of neurosciences

Molecular biology reports

Journal of lipid and atherosclerosis

This page only lists publications with an associated author ORCID identifier.

Publications

Ruby Gupta, Roopa Shivashankar, Dimple Kondal, Kuppan Gokulakrishnan, Shivani Anil Patel, Mohammed K Ali, K M Venkat Narayan, Viswanathan Mohan, Nikhil Tandon, Dorairaj Prabhakaran
Association of pro-inflammatory cytokines, adipokines and hepatokine with incident diabetes in India: a nested case-control study within CARRS cohort. Acta diabetologica (2024)
Ruby Gupta, Roopa Shivashankar, Dimple Kondal, Kuppan Gokulakrishnan, Shivani Anil Patel, Mohammed K Ali, K M Venkat Narayan, Viswanathan Mohan, Nikhil Tandon, Dorairaj Prabhakaran
Association of pro-inflammatory cytokines, adipokines and hepatokine with incident diabetes in India: a nested case-control study within CARRS cohort. Acta diabetologica 61 (5) (2024)
Saravanakumar Sundararajan, Isaivani Jayachandran, Gautam Kumar Pandey, Saravanakumar Venkatesan, Anusha Rajagopal, Kuppan Gokulakrishnan, Muthuswamy Balasubramanyam, Viswanathan Mohan, Nagaraj Manickam
Metformin Reduces the Progression of Atherogenesis by Regulating the Sestrin2-mTOR Pathway in Obese and Diabetic Rats. Journal of lipid and atherosclerosis 12 (3) (2023)
Kuppan Gokulakrishnan, Joyappa Nikhil, Sreeraj Vs, Bharath Holla, Chinnasamy Thirumoorthy, Narasimhan Sandhya, Sonika Nichenametla, Harsh Pathak, Venkatarama Shivakumar, Monojit Debnath, Ganesan Venkatasubramanian, Shivarama Varambally
Altered Intestinal Permeability Biomarkers in Schizophrenia: A Possible Link with Subclinical Inflammation. Annals of neurosciences 29 (2-3) (2022)
Kuppan Gokulakrishnan, Gautam Kumar Pandey, Chandrakumar Sathishkumar, Saravanakumar Sundararajan, Prabhu Durairaj, Nagaraj Manickam, Viswanathan Mohan, Muthuswamy Balasubramanyam
Augmentation of RBP4/STRA6 signaling leads to insulin resistance and inflammation and the plausible therapeutic role of vildagliptin and metformin. Molecular biology reports 48 (5) (2021)